definiens: shall mean, with respect to a Manufacturing Facility fift ercent 50 % ) f the amounts incurred by CG with respect to such Manufacturing Facility under the Development Program, to the extent such amounts were specifically identified in the Development Program Plan and Budget as capital expenditures for the Manufacturing Facility and were reimbursed by JT hereunder ( including the amounts reimbursed under 19.4.2(a)(i)(A)(I ) ), less - the depreciation expense for such Manufacturing Facility not included in the Production Costs of Collaboration Products produced under this Agreement pursuant to Section 1.50(ii ) for clinical or commercial uses by, directly or indirectly, either CG or JT . It is understood and agreed that once any Unrecouped illvestment have been reimbursed through payment of the Manufacturing Royalty outlined above, such reimbursed amount shall cease thereafter to be Unrecouped illvestment for all purposes of this Section 19.4.2(a)(ii )